-

Computer-Aided Biology: The Metadata Responsibility

New whitepaper by Synthace highlights the crucial role of metadata in an AI and automation powered lab of the future

LONDON--(BUSINESS WIRE)--Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, is pleased to announce it has released a new comprehensive whitepaper entitled, Computer-Aided Biology: The Metadata Responsibility.

AI needs metadata
The future of biological research and development must be built on a foundation of well-contextualised data. The integration of technologies such as artificial intelligence, lab automation, and the internet of things is beginning to enable researchers to address ever-more-complex biological questions across a rapidly expanding bioeconomy. However, the ability to use these tools successfully requires a fundamental shift in how we generate biological data. Data is of value when it is associated with contextual metadata of how the data was produced. It is therefore imperative that rich metadata is harvested at the point of data creation and associated with that data in a complete data package.

According to the report, many initiatives are being formed to enable the sharing or structuring of biological data - with the end goal being the ability to leverage artificial intelligence. However, to complement these initiatives, it is important to focus on how this data is being generated in the lab. Critically, systems that allow for the smart definition and capture of richer datasets at the beginning of the data journey will be vital to unlocking AI's power in the experimental sciences.

"We are pleased to offer these insights around the importance of collecting comprehensive metadata," said Tim Fell, CEO Synthace. "In this follow up to our pioneering whitepaper Computer-Aided Biology: Delivering biotechnology in the 21st century, we highlight the crucial responsibility to define, capture, and combine metadata at the point of creation. The current practice where users spend considerable time trying to back contextualise experimental datasets is not fit for purpose in an AI and automation powered laboratory."

"This whitepaper shows that Synthace is a leading voice in the global conversation about how to make biotechnology more of an engineering discipline. This is also why we have built our Antha platform, which solves the challenges of collecting comprehensive metadata at the time a biological experiment is performed," Fell concluded.

The full detailed whitepaper can be found on the following link https://synthace.com/metadata-whitepaper.

-ENDS-

Tweet this: News! @Synthace announces the launch of its pioneering whitepaper, Computer-Aided Biology: The Metadata Responsibility, highlighting the crucial role of metadata in an AI and automation powered lab of the future. Read here: https://synthace.com/metadata-whitepaper #AI #Automation #Biotech #metadata #LaboftheFuture

Follow Synthace
Synthace Blog
Join the Twitter Conversation
Join us on LinkedIn

About Synthace
Based in London, UK, and Boston, the US, Synthace is accelerating biological discovery & optimisation through computer-aided biology. Our cloud software platform, Antha, empowers biologists by enabling them to flexibly program their lab automation without the need to code. The graphical user interface has been designed by biologists for biologists, intuitively enabling them to automate their whole experiment from planning to execution, data collection, and analysis. Antha is the cornerstone of the lab of the future, seamlessly connecting the digital realm of data with the physical of lab automation and wet-lab biology, automatically collecting and structuring data to accelerate biological understanding. Synthace is unlocking the potential of biology for humankind and our environment. Synthace works with biopharmaceutical companies, and in 2016 was recognized by the World Economic Forum as a Technology Pioneer that is helping shape the Fourth Industrial Revolution, and in 2018 as a Cool Vendor by Gartner.

Visit: www.synthace.com

Contacts

Press Enquiries
Courtney Glymph
Head of PR
c.glymph@synthace.com
07867488769

Synthace Ltd


Release Versions

Contacts

Press Enquiries
Courtney Glymph
Head of PR
c.glymph@synthace.com
07867488769

More News From Synthace Ltd

Synthace's New Report Reveals Challenges and Opportunities in Life Science R&D Experiments

LONDON & BOSTON--(BUSINESS WIRE)--Synthace, the leading digital experiment platform for life science R&D teams, has released a comprehensive analyst report titled Lab automation & experimentation in life science R&D 2023-2024. The report sheds light on the industry challenges faced by researchers and highlights opportunities for improvement. By addressing key themes such as data management, automation hurdles, burdens placed on individual scientists, and lack of support, Synthace ai...

 Synthace combines ChatGPT and digital experiments in first step toward a true AI scientist

LONDON & BOSTON--(BUSINESS WIRE)--Synthace, creators of the world’s first digital experiment platform for life science R&D, today announces the successful integration of their platform with OpenAI’s ChatGPT. This revolutionary development lets scientists use a natural language interface to describe their intent, use the AI to design complex experiments, and then run those experiments on lab equipment. Watch the video here: https://www.youtube.com/watch?v=IPwI6Us57iM At a glance: what Syntha...

Synthace, a Digital Experiment Platform for Life Science R&D, Records Strongest Year Yet

LONDON & BOSTON--(BUSINESS WIRE)--Today, Synthace, a digital life science experiment platform, announces it has had its most successful year on record with major adoption and expansion with customers, industry recognition, product innovation, and a key hire at board level. Major adoption and expansion among the top 100 pharma Synthace experienced 94% annual recurring revenue growth, 166% year-on-year growth in total contract value, and 170% net revenue retention (NRR) growth among customers. Tr...
Back to Newsroom